TABLE 2.
Novel Therapeutic Target | Mechanism of action |
---|---|
Adiponectin replacement | Increase fatty acid oxidation, reduce oxidative stress and liver fibrosis |
Leptin replacement | Promote lipid mobilization, reduce liver fat deposition |
TZDs (PPAR‐γ agonist) | Increase circulating adiponectin levels, regulate inflammation, improve fibrosis |
SGLT‐2 inhibitor | Reduce ectopic fat, reverse hepatic fibrosis |